Form 4 Tracker
Howard W Robin

Director, President & CEO · 4 filings · Latest: Jul 24, 2026

NEKTAR THERAPEUTICS
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
NKTR
Howard W RobinDirector, President & CEOJun 17, 2026
Sale
$61.1910,000$611.9K55,045
NKTR
Howard W RobinDirector, President & CEOJun 16, 2026
Sale
$60.3210,000$603.2K65,045
NKTR
ROBIN HOWARD WJun 17, 2026
Proposed Sale
$60.2710,000$602.7K
NKTR
ROBIN HOWARD WJun 16, 2026
Proposed Sale
$60.9610,000$609.6K
NKTR
Howard W RobinDirector, President & CEOMay 19, 2026
Sale
$65.51444$29.1K75,045
NKTR
ROBIN HOWARD WMay 19, 2026
Proposed Sale
$65.51444$29.1K
NKTR
Howard W RobinDirector, President & CEOFeb 18, 2026
Sale
$73.00423$30.9K75,489
NKTR
ROBIN HOWARD WFeb 18, 2026
Proposed Sale
$73.00423$30.9K
NKTR
ROBIN HOWARD WNov 25, 2025
Proposed Sale
$58.822,207$129.8K
NKTR
ROBIN HOWARD WSep 9, 2025
Proposed Sale
$46.696,666$311.2K
NKTR
ROBIN HOWARD WSep 5, 2025
Proposed Sale
$38.536,666$256.8K
NKTR
ROBIN HOWARD WSep 4, 2025
Proposed Sale
$33.705,166$174.1K
NKTR
ROBIN HOWARD WSep 2, 2025
Proposed Sale
$30.161,500$45.2K
NKTR
ROBIN HOWARD WAug 19, 2025
Proposed Sale
$26.591,573$41.8K
NKTR
ROBIN HOWARD WMay 19, 2025
Proposed Sale
$0.671323,208$15.6K
NKTR
ROBIN HOWARD WFeb 19, 2025
Proposed Sale
$1.0123,774$24.0K
NKTR
ROBIN HOWARD WDec 18, 2024
Proposed Sale
$0.990785,035$84.2K
NKTR
ROBIN HOWARD WDec 17, 2024
Proposed Sale
$1.0146,995$47.3K
NKTR
ROBIN HOWARD WNov 19, 2024
Proposed Sale
$1.0116,278$16.5K